Fibrodysplasia ossificans progressiva (FOP) is a congenital disorder of progressive and widespread postnatal ossification of soft tissues. 1 Patients with classical FOP have congenital malformations that result in profoundly decreased mobility. 2, 3 Recently, a recurrent mutation (R206H) within ACVR1/ALK2, bone morphogenetic protein (BMP) type I receptor, was identified in both familial and sporadic patients with FOP. 4 Because this mutation induced the activation of BMP signaling in ectopic bone formation, BMP signaling inhibitors could offer therapeutic benefits for FOP. 5, 6 Therefore, we screened inhibitors of BMP-induced alkaline phosphatase (ALP) activity using a stable ALK2(R206H)-expressing C2C12 cell line (abbreviated as C2C12(R206H) cells). 7 During the course of this screening program, we reported pyrrolidine-containing compounds produced by fungal strain Fusarium sp. B88 7 and trichocyalides produced by fungal strain Trichoderma sp. FKI-5513 8 as potential inhibitor candidates for osteoblastic differentiation. Continuing this screening, a new active compound, designated 5-prenyltryptophol (5-PT, Figure 1 ), was isolated from the culture broth of actinomycete strain Streptomyces colinus subsp. albescens HEK608.
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The producing microorganism S. colinus subsp. albescens HEK608, classified on the basis of the partial sequence of 16S rRNA genes (data not shown), was isolated from soil collected in Hegurajima, Wajima-shi, Ishikawa Prefecture, Japan. A loopful of spores of strain HEK608 was inoculated into 100 ml seed medium consisting of 1.0% starch, 0.5% glucose, 0.3% NZ-Case (Sigma-Aldrich, St Louis, MO, USA), 0.2% yeast extract (Oriental Yeast, Itabashi-ku, Tokyo, Japan), 0.5% Bacto-tryptone (Becton Dickinson and Company, Franklin Lakes, NJ, USA), 0.1% K 2 HPO 4 , 0.05% MgSO 4 7H 2 O, 0.3% CaCO 3 (adjusted to pH 7.0 before sterilization) in a 500-ml Erlenmeyer flask. The inoculated Erlenmeyer flask was incubated in a rotary shaker (210 r.p.m.) at 30 1C for 3 days to obtain the seed culture. For the production of 5-PT, the culture was initiated by transferring 3 ml seed culture into 25 Â 500 ml Erlenmeyer flasks containing production medium (0.5% glucose, 2.0% glycerol, 2.0% soluble starch, 1.5% pharmamedia (Southern Cotton Oil, Richmond, TX, USA), 0.3% yeast extract, 1% Diaion HP-20 (Mitsubishi Chemical, Tokyo, Japan), non-adjusted pH) and fermentation was carried out in a rotary shaker (210 r.p.m.) at 30 1C for 7 days.
The culture broth (2.5 l) was centrifuged at 8000 r.p.m. for 15 min to obtain the mycelium. The mycelium was treated with acetone (2.5 l) for 1 h, and acetone extracts were filtered to remove the mycelium. After concentration of the extracts to remove acetone, the aqueous solution was adjusted to pH 9.0 and extracted with EtOAc (2.5 l). The organic layer was dried over Na 2 SO 4 and concentrated under reduced pressure to give brown materials (1.24 g). The materials were dissolved in a small amount of MeOH and purified by octa decyl silyl (ODS) column chromatography (i.d. 3.5 Â 16 cm, Chromatorex ODS, 100-200 mesh; Fuji Silysia Chemical, Aichi-ken, Japan). The active materials were eluted stepwise with CH 3 CN-H 2 O (0, 20, 40, 60, 80 and 100%, 160 ml each). 5-PT was recovered from the 80% CH 3 CN-H 2 O fraction, which was concentrated under reduced pressure to give brown oily materials (48.8 mg). The materials containing 5-PT were dissolved in MeOH and finally purified by HPLC under the following conditions: column, CAPCELL PAK C18 (i.d. 20 Â 250 mm; Shiseido, Tokyo, Japan); mobile phase, a linear gradient from 40 to 70% CH 3 CN for 45 min; flow rate, 8 ml min À1 ; detection, UV 210 nm. 5-PT was eluted as a peak with a retention time of 24 min. The fraction of the peak was collected and concentrated to dryness to give pure 5-PT (1.2 mg) as a yellow powder.
The physico-chemical properties of 5-PT are summarized in Table 1 . In UV spectra, 5-PT showed absorption maxima at 225, 280 and 341 in MeOH, suggesting the presence of an indole chromophore. In IR spectra, broad OH and/or NH absorption near at 3408 cm À1 , typical C-H (CH 2 ) stretching absorptions at 2926 cm À1 and aromatic C-C stretch absorptions (for carbon-carbon bonds in the aromatic ring) at 1655 and 1439 cm À1 were observed. (Table 2) showed 17 proton and 15 carbon signals, which were confirmed by analysis of 2D NMR correlations. The multiplicity of the carbon signals was classified into two methyl carbons, two sp 3 methylene carbons, one sp 3 oxygenated methylene carbon, four sp 2 methine carbons, one sp 2 nitrogenated methine carbon, four sp 2 quaternary carbons and one sp 2 nitrogenated quaternary carbon by analysis of DEPT and HMQC data. The connectivity of proton and carbon atoms was established by HMQC ( Table 2 ). As shown in Figure 2 , the partial structures I to III were elucidated by 1 H-1 H COSY spectra. The 13 C-1 H long-range couplings of 2 J and 3 J in the HMBC spectra (Figure 2 9 ) and from the methyl proton H 3 -14 to C-11, C-12 and the methyl carbon C-14 (d 17.6) suggested the presence of indole group containing the partial structure II. This isoprenyl group was connected to the indole moiety at C-5 by observation of the 3 J cross peaks from H-4 and H-6 to the sp 3 methylene carbon C-10 (d 35.5), from H-10 to C-4, C-5 and C-6 and from the sp 2 methine proton H-11 (d 5.37) to C-5 in HMBC experiments; (3) Long-range couplings from the sp 3 methylene proton H 2 -8 (d 2.94) to the sp 2 methine carbon C-2 (d 123.7), C-3 and C-3a and from the sp 3 oxygenated methylene proton H-9 (d 3.79) to C-3 showed that a 9-oxyethyl group containing the partial structure III attached to the indole moiety at C-3. Furthermore, the chemical shifts of C-9 (d C 63.7, d H 3.79) indicated that a hydroxyl group is attached to C-9. Taking these observations into consideration, the structure of 5-PT was elucidated 
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as shown in Figure 1 , which fulfilled the molecular formula and the degrees of unsaturation. BMP-induced ALP inhibitory activity and cytotoxicity of 5-PT in C2C12(R206H) cells were measured according to the previously reported method (details in Supplementary Information). 7, 8 C2C12 cells expressed ALP activity as an osteogenic phenotype in the presence of high concentrations of recombinant BMP. Therefore, ALP activity was used as a typical marker of BMP signaling in the C2C12 cell line. As a result, 5-PT exhibited ALP inhibitory activity and cytotoxicity with IC 50 values of 81.3 and 263 mM, respectively. Furthermore, in order to examine the direct effect of 5-PT on BMP signaling, we determined Id1WT4F-luc activity in C2C12 cells according to the previously reported method (details in Supplementary Information). 7, 8 However, 5-PT showed no effect on luciferase activity even at 43.6 mM, suggesting that the target of 5-PT does not lie within early events of Smads 6 but within late steps, the BMP signaling pathway. 5 The target of 5-PT in osteoblastic differentiation remains to be demonstrated.
